My HPRA: Register

The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


CLINIMIX N14G30E, solution for infusion



Baxter Holding B.V.PA2299/020/001

Main Information

Trade NameCLINIMIX N14G30E, solution for infusion
Active SubstancesL-leucine
L-phenylalanine
L-methionine
L-lysine
L-isoleucine
L-valine
L-histidine
L-threonine
L-tryptophan
L-alanine
L-arginine
Glycine
L-proline
L-serine
L-tyrosine
Sodium acetate trihydrate
Dibasic potassium phosphate
Sodium chloride
Magnesium chloride hexahydrate
Glucose
Calcium chloride dihydrate
Dosage FormSolution for infusion
Licence HolderBaxter Holding B.V.
Licence NumberPA2299/020/001

Group Information

ATC CodeB05BA Solutions for parenteral nutrition
B05BA01 amino acids

Status

License statusAuthorised
Licence Issued30/04/1996
Legal statusProduct subject to prescription which may not be renewed (A)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusMarketed

Documents

Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back
Follow medicine

Print